XORTX Therapeutics Inc. submitted a 6-K filing on March 19, 2025, indicating compliance with SEC regulations. It confirmed its intention to file annual reports under Form 20-F.
AI Assistant
XORTX THERAPEUTICS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.